Human IgM Antibodies Against HIV-1
Author Information
Author(s): Chen Weizao, Zhu Zhongyu, Liao Huaxin, Quinnan Gerald V. Jr., Broder Christopher C., Haynes Barton F., Dimitrov Dimiter S.
Primary Institution: National Cancer Institute (NCI)-Frederick, National Institutes of Health (NIH)
Hypothesis
Can human IgM-derived monoclonal antibodies effectively bind to HIV-1 envelope glycoproteins?
Conclusion
The study identified several human IgM-derived monoclonal antibodies that bind to HIV-1 envelope glycoproteins, but their neutralizing activity is limited.
Supporting Evidence
- The antibodies bound with high affinity to recombinant envelope glycoproteins of HIV-1 isolates from different clades.
- Some antibodies enhanced HIV-1 infection, while others did not neutralize it effectively.
- The study suggests that conserved structures on HIV-1 may direct immune responses to non-neutralizing antibodies.
Takeaway
Scientists found special antibodies in healthy people that can stick to a virus called HIV, but they don't work very well to stop the virus.
Methodology
The study involved constructing a large phage-displayed naive human antibody library from blood, lymph nodes, and spleens of healthy donors to identify IgM-derived antibodies against HIV-1.
Limitations
The antibodies exhibited weak neutralizing activity and may not represent native antibodies due to selection from phage libraries.
Participant Demographics
The antibodies were selected from a library constructed from blood, lymph nodes, and spleens of 59 healthy donors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website